BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 19, 2011 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Joseph Zakrzewski, Amarin’s Executive Chairman and Chief Executive Officer, is scheduled to present at the UBS Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York City. The presentation will take place at 3:30pm ET on September 21, 2011.
